SPEAKER INDEX CONTENTS INSERTS APPENDIX 4 CLARK 21 22 25 29 31 32 33 34 35 113 DOCUMENTS SUBMITTED FOR THE RECORD 5 FINE 63 64 65 66 67 68 69 70 71 72 73 74 75 GOZANI 75 76 78 79 80 81 82 83 84 85 86 88 89 90 113 HEARING 4 HOLLIS 105 106 107 108 109 110 111 112 HUNTER 6 10 11 13 14 15 19 20 22 25 28 33 35 39 40 41 42 43 44 47 52 53 54 55 56 58 59 62 63 64 65 66 67 68 69 73 75 76 78 79 80 81 82 83 84 85 87 88 91 92 93 94 95 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 LANGEVIN 33 42 43 48 58 59 61 62 72 73 LARSON 29 31 33 MEEHAN 8 17 18 19 56 69 70 71 72 99 100 101 114 MOLDT 35 39 40 41 42 43 44 45 46 47 114 MOTTUR 48 52 53 54 56 58 59 61 62 MULLIGAN 11 14 15 16 17 18 19 20 113 PREPARED STATEMENTS 5 QUESTIONS AND ANSWERS SUBMITTED FOR THE RECORD 5 RAUSCH 91 92 94 95 97 98 99 100 101 102 103 104 REYES 18 46 47 53 54 55 56 81 84 85 86 87 88 SANCHEZ 40 44 45 SAXTON 73 74 75 88 90 THOMPSON 15 CONTENTS SPEAKERS INSERTS OPENING STATEMENT OF HON. DUNCAN HUNTER, A REPRESENTATIVE FROM CALIFORNIA, CHAIRMAN, MILITARY RESEARCH AND DEVELOPMENT SUBCOMMITTEE PAGE 6 STATEMENT OF ANTHONY MULLIGAN, PRESIDENT, ADVANCED CERAMICS RESEARCH PAGE 11 STATEMENT OF LAWRENCE CLARK, CHAIRMAN OF THE BOARD, SONALYSTS PAGE 21 STATEMENT OF VERA MOLDT, VICE PRESIDENT CORPORATE DEVELOPMENT, AMBIENT CONTROL SYSTEM PAGE 35 STATEMENT OF PETER MOTTUR, CEO, LIVEWAVE PAGE 48 STATEMENT OF DAVID FINE, CEO CYTERRA CORPORATION PAGE 63 STATEMENT OF TSAHI GOZANI, PRESIDENT AND CEO, ANCORE PAGE 76 STATEMENT OF CARL RAUSCH, CHAIRMAN AND CEO, BIOPURE PAGE 91 STATEMENT OF RICHARD HOLLIS, PRESIDENT AND CEO, HOLLIS EDEN PHARMACEUTICALS PAGE 105 INSERTS SPEAKERS CONTENTS NO INSERTS IN THIS HEARING